Insider · CIK 0001574139

Sofinnova Partners SAS

CIK 0001574139 Name as filed on the most recent filing

Filed as Sofinnova Partners SAS (21)

23 transaction lines · from 21 filings · filed 2013-04-18 to 2022-08-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

2 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-08-15 P, Open-market purchase CinCor Pharma, Inc.CINC 3,999,990, acquired Open Form 4 filing 0001209191-22-046250
2022-01-11 P, Open-market purchase CinCor Pharma, Inc.CINC 3,520,000, acquired Open Form 4 filing 0001209191-22-003195
2021-04-21 S, Open-market sale Hookipa Pharma Inc.HOOK 3,812,386, disposed Open Form 4 filing 0001104659-21-054478
2021-03-29 S, Open-market sale Hookipa Pharma Inc.HOOK 503,570, disposed Open Form 4 filing 0001104659-21-044737
2021-03-26 S, Open-market sale Hookipa Pharma Inc.HOOK 481,642, disposed Open Form 4 filing 0001104659-21-044238
2021-03-25 S, Open-market sale Hookipa Pharma Inc.HOOK 374,569, disposed Open Form 4 filing 0001104659-21-043143
2021-03-24 S, Open-market sale Hookipa Pharma Inc.HOOK 721,616, disposed Open Form 4 filing 0001104659-21-042621
2021-03-23 S, Open-market sale Hookipa Pharma Inc.HOOK 556,476, disposed Open Form 4 filing 0001104659-21-041618
2021-03-22 S, Open-market sale Hookipa Pharma Inc.HOOK 589,263, disposed Open Form 4 filing 0001104659-21-041049
2021-03-19 S, Open-market sale Hookipa Pharma Inc.HOOK 2,427,739, disposed Open Form 4 filing 0001104659-21-040331
2020-10-02 S, Open-market sale Hookipa Pharma Inc.HOOK 3,000, disposed Open Form 4 filing 0001104659-20-112628
2020-09-15 S, Open-market sale Hookipa Pharma Inc.HOOK 2 lines 524,477, disposed Open Form 4 filing 0001104659-20-106098
2020-07-20 S, Open-market sale Hookipa Pharma Inc.HOOK 149,102, disposed Open Form 4 filing 0001104659-20-085613
2020-06-29 S, Open-market sale Hookipa Pharma Inc.HOOK 38,628, disposed Open Form 4 filing 0001104659-20-086507
2020-06-29 S, Open-market sale Hookipa Pharma Inc.HOOK 38,628, disposed Open Form 4 filing 0001104659-20-079717
2020-06-29 S, Open-market sale Hookipa Pharma Inc.HOOK 38,628, disposed Open Form 4 filing 0001104659-20-085615
2019-04-23 P, Open-market purchase Hookipa Pharma Inc.HOOK 4,999,988, acquired Open Form 4 filing 0001104659-19-023694
2014-10-29 S, Open-market sale Flexion Therapeutics IncFLXN 200,000, disposed Open Form 4 filing 0001144204-15-003241
2014-02-18 P, Open-market purchase Flexion Therapeutics IncFLXN 2,999,997, acquired Open Form 4 filing 0001209191-14-012245
2013-05-14 P, Open-market purchase BioAmber Inc.BIOA.U Not reported Open Form 4 filing 0001181431-13-028416
2013-04-16 S, Open-market sale Omthera Pharmaceuticals, Inc.OMTH 1,568, disposed Open Form 4 filing 0001179110-13-006939
2013-04-16 P, Open-market purchase Omthera Pharmaceuticals, Inc.OMTH 5,000,000, acquired Open Form 4 filing 0001179110-13-006939

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 1
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Sofinnova Partners SAS, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001574139

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.